Ranitidine bismuth citrate

Canadian Journal of Gastroenterology

Volumn 15, Issue 6, 2001, Pages 389-398

  Chiba, N ^a   Hunt, R H ^a   Thomson, A B R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Helicobacter pylori treatment

Indexed keywords

AMOXICILLIN; BISMUTH; BISMUTH CITRATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; OXYTETRACYCLINE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; RANITIDINE BISMUTH CITRATE; SPIRAMYCIN; STOMACH SECRETION INHIBITOR; TETRACYCLINE; TINIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DUODENUM ULCER; GASTROINTESTINAL DISEASE; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; MULTICENTER STUDY; NAUSEA AND VOMITING; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REVIEW; STOMACH ULCER; UPPER RESPIRATORY TRACT INFECTION; VERTIGO;

EID: 0034915082     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/925106     Document Type: Review

References (65)

1. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease
2. Helicobacter pylori: New developments and treatments
3. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease
4. Canadian Helicobacter pylori Consensus Conference
5. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori
6. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial
7. New options in Helicobacter pylori eradication: Efficacy, resistance and synergy
8. Review: Eradication of Helicobacter pylori. Problems and recommendations
9. Canadian Helicobacter pylori Consensus Conference update: Infections in adults
10. Current European concepts in the management of Helicobacter pylori infection. The Mäastricht Consensus report
11. SM International Update Conference on Helicobacter pylori
12. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
13. Ranitidine bismuth citrate: A novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture
14. The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity
15. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection
16. Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens
17. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate
18. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer
19. Ranitidine bismuth citrate plus clarithromycin is effective for healing DU, eradicating H pylori and reducing ulcer recurrence
20. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer
21. Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing
22. An alternative non-macrolide, non-imidazole treatment regimen for curing Helicobacter pylori and DU: Ranitidine bismuth citrate plus amoxicillin
23. Dual and triple therapy regimens of antisecretory agents and antibiotics for the eradication of Helicobacter pylori: An Overview
24. Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: A review
25. Ranitidine bismuth citrate plus clarithromycin: A dual therapy regimen for patients with duodenal ulcer
26. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals DU
27. Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori
28. Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H.pylori and healing of duodenal ulcer
29. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer
30. Ranitidine bismuth citrate with clarithromycin given alone or with metronidazole for 7 days effectively eradicates H pylori
31. Ranitidine bismuth citrate (RBC) co-prescribed with clarithromycin is more effective in the eradication of Helicobacter pylori than omeprazole with clarithromycin
32. Ranitidine bismuth citrate in combination with clarithromycin is effective against H pylori strains with susceptible or intermediate clarithromycin sensitivity
33. Development of clarithromycin resistance is 2.7 times less likely with ranitidine bismuth citrate than with omeprazole
34. Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection
35. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): A randomized comparison between two 7-day triple therapies and a 14-day dual therapy
36. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: A randomized, clinical trial
37. High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate
38. Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection
39. A new 1-week therapy for Helicobacter pylori eradication: Ranitidine bismuth citrate plus two antibiotics
40. Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate
41. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication
42. One-week therapy for Helicobacter pylori eradication: Ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin
43. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori
44. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer
45. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer
46. Helicobacter pylori eradication with PPI-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy
47. Bismuth, metronidazole and tetracycline (BMT) ± cid suppression in H pylori eradication: A meta-analysis
48. Spiramycin is comparable to oxytetracycline in eradicating H pylori when given with ranitidine bismuth citrate and metronidazole
49. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: A prospective randomized controlled trial
50. Eradication of Helicobacter pylori infection after ranitidine bismuth citrate, metronidazole and tetracycline for 7 or 10 days
51. Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection
52. Sevenday treatment for Helicobacter pylori infection: Ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride
53. Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection
54. Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection
55. Ranitidine bismuth citrate enhances clarithromycin activity against clinical isolates of H pylori
56. The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics
57. The synergistic interaction between GR122311X and clarithromycin against Helicobacter
58. Overcoming clarithromycin resistance with the combination of clarithromycin and ranitidine bismuth citrate
59. Ranitidine bismuth citrate can overcome in vitro antibiotic resistance in Helicobacter pylori
60. Synergism study of ranitidine bismuth citrate and metronidazole against metronidazole resistant H pylori clinical isolates
61. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection
62. Review article: Safety of bismuth in the treatment of gastrointestinal diseases
63. Long-term safety analysis of ranitidine bismuth citrate in Helicobacter pylori-infected subjects with upper gastrointestinal symptoms
64. The safety of ranitidine bismuth citrate in controlled clinical studies
65. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection